| Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells. | |
| | |
MedLine Citation:
|
PMID: 11172589 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Arsenic trioxide (As2O3) has been shown to inhibit the proliferation of hematologic malignant cells. Previously, we reported that As2O3 had an antitumoral effect in head and neck cancer. Here, we investigated the induction of apoptosis and its mechanism in PCI-1 head and neck squamous carcinoma cells, after treatment with As2O3. Treatment with 2 microM of As2O3 caused apoptosis in PCI-1 cells following 3 days of exposure, which was detected by the annexin V-PI and DAPI staining methods. The cell death population was markedly increased, being 88% larger than the As2O3-untreated control cells. To address the mechanism of apoptosis, a Western blot assay was performed, showing that Bax was up-regulated without a change in Bcl-2. Activation of caspase-9 during As2O3-induced apoptosis was substantiated by monitoring the proteolysis of the caspase-9, which was associated with an increase of Apaf-1 and cytochrome c protein. PCI-1 cells rapidly changed the mitochondria membrane potential (DeltaPsim) after addition of As2O3. Furthermore, activation of caspase-3 was demonstrated by monitoring the proteolysis of the caspase-3 and by measuring caspase-3 activity with a fluorogenic substrate, which was associated with the cleavage of poly(ADP-ribose) polymerase. To examine the in vivo effect of As2O3, C3H mouse inoculated with syngenic SCC7 cells was treated by intratumoral injection of As2O3 (300 microg) every day, demonstrating that tumor mass was dramatically reduced on day 4, and revealed induction of apoptosis by TUNEL assay. These results suggest that apoptosis of PCI-1 cells by As2O3 is induced by activation of caspase-3 via cytochrome c, caspase-9 and Apaf-1 complex. |
| | |
Authors:
|
J G Seol; W H Park; E S Kim; C W Jung; J M Hyun; Y Y Lee; B K Kim |
Related Documents
:
|
22508429 - The transition of acute to chronic bowel inflammation in spondyloarthritis. 15711929 - The expression of apoptosis related genes in the first trimester human placenta using a... 9380409 - The apoptosis-necrosis paradox. apoptogenic proteases activated after mitochondrial per... 19029949 - Calpain small-1 modulates akt/foxo3a signaling and apoptosis through pp2a. 21478439 - Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (pfapa) is a disorder of... 20640889 - Caspase-3 triggers a tpck-sensitive protease pathway leading to degradation of the bh3-... 11751959 - The cd8 t cell compartment plays a dominant role in the deficiency of brown-norway rats... 398149 - Alveolar macrophage--induced suppression of the immune response. 9373219 - Activation of t-cells through an antigen-independent alternative pathway induces precoc... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of oncology Volume: 18 ISSN: 1019-6439 ISO Abbreviation: Int. J. Oncol. Publication Date: 2001 Feb |
Date Detail:
|
Created Date: 2001-02-22 Completed Date: 2001-05-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9306042 Medline TA: Int J Oncol Country: Greece |
Other Details:
|
Languages: eng Pagination: 249-55 Citation Subset: IM |
Affiliation:
|
Cancer Research Center, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antineoplastic Agents / pharmacology*, therapeutic use Apoptosis / drug effects*, physiology Apoptotic Protease-Activating Factor 1 Arsenicals / pharmacology*, therapeutic use Carcinoma, Squamous Cell / drug therapy, metabolism* Caspase 3 Caspase 9 Caspases / drug effects*, metabolism Head and Neck Neoplasms / drug therapy, metabolism* Humans Membrane Potentials / drug effects, physiology Mice Mitochondria / drug effects, metabolism Oxides / pharmacology*, therapeutic use Proteins / drug effects, metabolism Tumor Cells, Cultured / drug effects, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/APAF1 protein, human; 0/Antineoplastic Agents; 0/Apaf1 protein, mouse; 0/Apoptotic Protease-Activating Factor 1; 0/Arsenicals; 0/Oxides; 0/Proteins; 1327-53-3/arsenic trioxide; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/CASP9 protein, human; EC 3.4.22.-/Casp3 protein, mouse; EC 3.4.22.-/Casp9 protein, mouse; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspase 9; EC 3.4.22.-/Caspases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines.
Next Document: Expression and function of interleukin-8 in human hepatocellular carcinoma.